Investment Partners’s Biogen BIIB Stock Holding History

Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,100	Closed	-$294K	–	133
2020 Q2	$294K	Hold	1,100	–	–	0.17%	97
2020 Q1	$348K	Buy	1,100 +100	+10%	+$30.3K	0.25%	82
2019 Q4	$297K	Sell	1,000 -100	-9%	-$27.7K	0.2%	110
2019 Q3	$256K	Hold	1,100	–	–	0.19%	120
2019 Q2	$257K	Buy	1,100 +100	+10%	+$23.1K	0.18%	120
2019 Q1	$236K	Sell	1,000 -100	-9%	-$31.5K	0.17%	125
2018 Q4	$331K	Buy	+1,100	New	+$351K	0.28%	82
2018 Q3	–	Sell	-1,000	Closed	-$290K	–	128
2018 Q2	$290K	Hold	1,000	–	–	0.22%	100
2018 Q1	$274K	Hold	1,000	–	–	0.2%	112
2017 Q4	$319K	Hold	1,000	–	–	0.24%	100
2017 Q3	$313K	Hold	1,000	–	–	0.27%	87
2017 Q2	$271K	Hold	1,000	–	–	0.25%	94
2017 Q1	$273K	Hold	1,000	–	–	0.26%	89
2016 Q4	$284K	Sell	1,000 -66	-6%	-$19.6K	0.28%	88
2016 Q3	$334K	Buy	1,066 +66	+7%	+$19.5K	0.19%	123
2016 Q2	$242K	Sell	1,000 -66	-6%	-$17.4K	0.24%	96
2016 Q1	$327K	Buy	1,066 +66	+7%	+$17.4K	0.21%	116
2015 Q4	$306K	Hold	1,000	–	–	0.37%	75
2015 Q3	$292K	Hold	1,000	–	–	0.38%	72
2015 Q2	$404K	Hold	1,000	–	–	0.49%	70
2015 Q1	$422K	Hold	1,000	–	–	0.46%	70
2014 Q4	$339K	Buy	+1,000	New	+$324K	0.39%	73

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Investment Partners's BIIB Position: Q3 2020 in Review

Investment Partners sold out of Biogen (BIIB) in Q3 2020, closing a stake of 1,100 shares — an estimated $294K sold.

Investment Partners first reported a position in BIIB in Q4 2014 and held it in 22 quarters. The position peaked at $422K in Q1 2015. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

Investment Partners reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
Investment Partners sold 1,100 Biogen shares in Q3 2020, an estimated $294K.
Investment Partners first reported a position in Biogen in Q4 2014 and held it in 22 quarters.
Investment Partners's Biogen position peaked at $422K in Q1 2015.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Investment Partners's 13F filing for Q3 2020, filed 9 Nov 2020.